Advertisement

Advertisement

RPRX Stock Latest News

Astera Labs (ALAB) and Bloom Energy (BE) Soar as Investors Bet on S&P 500 Index (SPX) Inclusion

Market NewsAstera Labs (ALAB) and Bloom Energy (BE) Soar as Investors Bet on S&P 500 Index (SPX) Inclusion

Zealand Pharma enters $100M royalty purchase, sale pact with Royalty Pharma

PremiumThe Fly

Zealand Pharma enters $100M royalty purchase, sale pact with Royalty Pharma

1M ago

Royalty Pharma lifts 2026 outlook amid strong cash flows

PremiumCompany Announcements

Royalty Pharma lifts 2026 outlook amid strong cash flows

1M ago

3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy

PremiumMarket News

3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy

1M ago

Royalty Pharma price target raised to $66 from $59 at Goldman Sachs

PremiumThe Fly

Royalty Pharma price target raised to $66 from $59 at Goldman Sachs

2M ago

Royalty Pharma price target raised to $65 from $64 at Morgan Stanley

PremiumThe FlyRoyalty Pharma price target raised to $65 from $64 at Morgan Stanley

2M ago

Royalty Pharma price target raised to $70 from $66 at Citi

The Fly

Royalty Pharma price target raised to $70 from $66 at Citi

2M ago

Royalty Pharma reports Q2 revenue $647M, consensus $758.88M

The Fly

Royalty Pharma reports Q2 revenue $647M, consensus $758.88M

2M ago

Royalty Pharma buys royalty interest in AstraZeneca cliramitug for $125M upfront

PremiumThe Fly

Royalty Pharma buys royalty interest in AstraZeneca cliramitug for $125M upfront

2M ago

Royalty Pharma price target raised to $65 from $50 at TD Cowen

PremiumThe Fly

Royalty Pharma price target raised to $65 from $50 at TD Cowen

2M ago

Royalty Pharma Shareholders Back Board, Pay and Flexibility

PremiumCompany Announcements

Royalty Pharma Shareholders Back Board, Pay and Flexibility

4M ago

Royalty Pharma Secures New $1.8 Billion Credit Facility

PremiumCompany Announcements

Royalty Pharma Secures New $1.8 Billion Credit Facility

4M ago

Royalty Pharma price target raised to $64 from $63 at Morgan Stanley

PremiumThe FlyRoyalty Pharma price target raised to $64 from $63 at Morgan Stanley

5M ago

Royalty Pharma price target raised to $58 from $50 at JPMorgan

The Fly

Royalty Pharma price target raised to $58 from $50 at JPMorgan

5M ago

Royalty Pharma price target raised to $66 from $50 at Citi

The Fly

Royalty Pharma price target raised to $66 from $50 at Citi

5M ago

Royalty Pharma’s Earnings Call Signals Confident Growth

PremiumCompany Announcements

Royalty Pharma’s Earnings Call Signals Confident Growth

5M ago

Royalty Pharma price target raised to $57 from $51 at UBS

PremiumThe Fly

Royalty Pharma price target raised to $57 from $51 at UBS

5M ago

Royalty Pharma: Leveraged Biopharma Catalysts and De-Risked Royalty Growth Support Further Upside

PremiumRatings

Royalty Pharma: Leveraged Biopharma Catalysts and De-Risked Royalty Growth Support Further Upside

5M ago

Royalty Pharma Expands Daraxonrasib Royalty Stake After Milestone

PremiumCompany Announcements

Royalty Pharma Expands Daraxonrasib Royalty Stake After Milestone

5M ago

Royalty Pharma price target raised to $63 from $61 at Morgan Stanley

PremiumThe FlyRoyalty Pharma price target raised to $63 from $61 at Morgan Stanley

5M ago

Royalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804

The Fly

Royalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804

6M ago

Zymeworks price target raised to $48 from $33 at Evercore ISI

The Fly

Zymeworks price target raised to $48 from $33 at Evercore ISI

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >